$TPTX Turning Point Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Turning Point Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Turning Point Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Turning Point Therapeutics, Inc. for free.

CIK Number: 0001595893
IRS Number: 463826166
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: TPTX
Company Address: 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO 92121
Phone number: 858-926-5251
Former name: TP Therapeutics, INC, date of change: 2014-01-06

Turning Point Therapeutics, Inc. engages in the discovery and development of precision medicines for cancer and other diseases. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by J. Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.

Turning Point Therapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Countouriotis AthenaPresident & CEO26,8720shares bought: 26,872 / shares sold: 0 STRONG BUYMay 26 20204 days ago
Cui Jingrong JeanDirector625,1830shares bought: 109,164 / shares sold: -811,000 STRONG SELLMay 21 20209 days ago
George SimeonDirector2,253,6600shares bought: 2,253,660 / shares sold: 0 STRONG BUYMay 26 20204 days ago
GLAXOSMITHKLINE PLCDirector2,253,6600shares bought: 2,253,660 / shares sold: 0 STRONG BUYMay 26 20204 days ago
Reich SiegfriedEVP & Chief Scientific Officer00Mar 02 20203 months ago

View all Turning Point Therapeutics, Inc. insiders.

Turning Point Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 26 2020TPTXTurning Point Ther ...George SimeonDirectorBuyP60.0083,3334,999,9802,253,6602.2 M to 2.3 M (+3.84 %)
May 26 2020TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOBuyP60.004,166249,96026,87222.7 K to 26.9 K (+18.35 %)
May 26 2020TPTXTurning Point Ther ...GLAXOSMITHKLINE PLCDirectorBuyP60.0083,3334,999,9802,253,6602.2 M to 2.3 M (+3.84 %)
May 21 2020TPTXTurning Point Ther ...Cui Jingrong JeanDirectorSellS60.341006,034605,383605.5 K to 605.4 K (-0.02 %)
May 21 2020TPTXTurning Point Ther ...Cui Jingrong JeanDirectorSellS59.646,900411,516605,483612.4 K to 605.5 K (-1.13 %)
May 21 2020TPTXTurning Point Ther ...Cui Jingrong JeanDirectorSellS60.981,40085,372612,383613.8 K to 612.4 K (-0.23 %)
May 21 2020TPTXTurning Point Ther ...Cui Jingrong JeanDirectorSellS60.035,100306,153613,783618.9 K to 613.8 K (-0.82 %)
May 21 2020TPTXTurning Point Ther ...Cui Jingrong JeanDirectorSellS59.0450029,520618,883619.4 K to 618.9 K (-0.08 %)
May 21 2020TPTXTurning Point Ther ...Cui Jingrong JeanDirectorSellS58.9440023,576619,383619.8 K to 619.4 K (-0.06 %)
May 21 2020TPTXTurning Point Ther ...Cui Jingrong JeanDirectorSellS58.363,000175,080619,783622.8 K to 619.8 K (-0.48 %)
May 21 2020TPTXTurning Point Ther ...Cui Jingrong JeanDirectorSellS57.442,400137,856622,783625.2 K to 622.8 K (-0.38 %)
May 21 2020TPTXTurning Point Ther ...Cui Jingrong JeanDirectorSellS56.331,20067,596625,183626.4 K to 625.2 K (-0.19 %)
May 12 2020TPTXTurning Point Ther ...Cui Jingrong JeanDirectorSellS55.161005,516626,383626.5 K to 626.4 K (-0.02 %)
May 12 2020TPTXTurning Point Ther ...Cui Jingrong JeanDirectorSellS54.494,750258,828626,483631.2 K to 626.5 K (-0.75 %)
May 12 2020TPTXTurning Point Ther ...Cui Jingrong JeanDirectorSellS53.495,920316,661631,233637.2 K to 631.2 K (-0.93 %)

View all Turning Point Therapeutics, Inc. insider transactions.